Ironwood Pharmaceuticals, Inc.
IRWD
$0.7267
-$0.0233-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.14% | -2.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.14% | -2.97% | |||
| Cost of Revenue | -363.11% | -1.85% | |||
| Gross Profit | 173.65% | -3.50% | |||
| SG&A Expenses | -6.99% | -1.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -10.55% | -1.51% | |||
| Operating Income | 23.05% | -6.53% | |||
| Income Before Tax | 38.15% | -7.98% | |||
| Income Tax Expenses | 58.41% | -30.47% | |||
| Earnings from Continuing Operations | -38.12% | 523.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -38.12% | 523.95% | |||
| EBIT | 23.05% | -6.53% | |||
| EBITDA | 20.67% | -3.60% | |||
| EPS Basic | -38.16% | 522.22% | |||
| Normalized Basic EPS | 38.68% | -18.95% | |||
| EPS Diluted | -29.50% | 470.37% | |||
| Normalized Diluted EPS | 39.09% | -19.19% | |||
| Average Basic Shares Outstanding | -0.16% | 0.44% | |||
| Average Diluted Shares Outstanding | -0.49% | 0.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||